{"version":"1.0","type":"link","title":"Phase I randomized double-blind parallel-group study: pharmacokinetics, safety, and immunogenicity of pertuzumab biosimilar SYSA1901 in healthy Chinese males.","author_name":"Xu Y 외","author_url":"https://prs-insight.online/author/Xu%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/88637","thumbnail_width":1200,"thumbnail_height":630}